|
Xu Binghe, Academician, Chief Physician, Doctoral Supervisor
Wuhan University , Medical School
Area of Focus
Breast Cancer | Malignant Tumors | Molecular Typing | Personalized Treatment | Drug Resistance | Cancer Research | Clinical Trials | Oncology | Medical Science | Treatment Guidelines |
|
Xueping Qiu, Associate Chief Physician
Wuhan University , Medical School
Area of Focus
Liver Cancer | Dna | Methylation | Biomarkers | Cancer Research | Molecular Biology | Genetics | Oncology | Medical Research | Clinical Trials |
|
Xuechuan Hong, Professor
Wuhan University , Medical School
Area of Focus
Nir-Ii Probes | Organic Molecules | Small Molecules | Tumor Visualization | Viral Mechanisms | Drug Development | Molecular Imaging | Biomedical Imaging | Cancer Research | Therapeutic Agents |
|
Jia Yu, Secretary of Scientific Research, Chief Physician, Associate Professor, Master Tutor
Wuhan University , Medical School
Area of Focus
Acute Pancreatitis | Extrapancreatic Organ Damage | Pathogenesis | Prevention | Treatment | Hepatocellular Carcinoma | Cancer Research | Medical Research | Clinical Studies | Surgical Intervention |
|
Jie Huang, Director, Professor, Master's Supervisor
Wuhan University , Medical School
Area of Focus
Lung Cancer | Metastasis | Molecular Biology | Cancer Research | Oncology | Cell Signaling | Gene Expression | Biomarkers | Targeted Therapy | Clinical Outcomes |
|
Jinxue He, Researcher
University of Chinese Academy of Sciences , Medical School
Area of Focus
Anti-Tumor | Drug Development | Mechanism Research | Dna Damage | Repair Pathway | Nuclear Protein | Intervention | Ubiquitin | Proteasome | New Drugs |
|
Shi-Lin Xu, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Anti-Tumor | Small Molecule | Drug Development | Cancer | Chemistry | Pharmacology | Biomedicine | Oncology | Medicinal Chemistry | Therapeutics |
|
Tao Meng, Researcher
University of Chinese Academy of Sciences , Medical School
Area of Focus
Targeted Therapy | Anti-Tumor | Drug Research | Antibody-Drug Conjugates | Cancer Treatment | Pharmacology | Chemotherapy | Biotechnology | Molecular Biology | Oncology |
|
Yi Li, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Anti-Tumor | Metabolic Diseases | Drug Development | Innovation | Research | Pharmaceuticals | Oncology | Metabolism | Therapeutics | Biochemistry |
|
Gang Xiao, Researcher of the 'Hundred Talents Program', Doctoral Supervisor
Zhejiang University, Medical School
Area of Focus
Hematologic Tumors | Metabolic Regulation | T Cells | Anti-Tumor | Immune Response | Pd-1 Receptor | B-Cell Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Cell Lineage Plasticity | Drug Resistance |
